Two Sigma Securities LLC acquired a new stake in shares of MetLife, Inc. (NYSE:MET – Free Report) in the second quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 49,691 shares of the financial services provider’s stock, valued at approximately $4,204,000.
Other hedge funds have also added to or reduced their stakes in the company. BlackRock Inc. purchased a new position in shares of MetLife in the 2nd quarter worth about $4,381,692,000. Pzena Investment Management LLC bought a new position in MetLife in the 2nd quarter worth about $941,792,000. Norges Bank purchased a new stake in MetLife during the 4th quarter valued at about $639,986,000. Bank of America Corp DE purchased a new stake in MetLife during the 2nd quarter valued at about $455,424,000. Finally, Legal & General Group Plc bought a new stake in MetLife during the 2nd quarter valued at about $326,904,000. 94.99% of the stock is owned by institutional investors.
MetLife Stock Performance
MET stock opened at $96.57 on Monday. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.20 and a quick ratio of 0.20. MetLife, Inc. has a 1 year low of $67.33 and a 1 year high of $100.93. The company has a market cap of $62.14 billion, a P/E ratio of 18.50, a price-to-earnings-growth ratio of 0.74 and a beta of 0.78. The stock’s fifty day moving average price is $93.39 and its 200-day moving average price is $82.88.
MetLife Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 8th. Stockholders of record on Tuesday, August 4th will be given a dividend of $0.5925 per share. The ex-dividend date of this dividend is Tuesday, August 4th. This represents a $2.37 annualized dividend and a dividend yield of 2.5%. MetLife’s dividend payout ratio is presently 45.40%.
MetLife announced that its Board of Directors has initiated a stock repurchase plan on Wednesday, August 5th that allows the company to buyback $3.00 billion in shares. This buyback authorization allows the financial services provider to purchase up to 4.8% of its stock through open market purchases. Stock buyback plans are usually a sign that the company’s management believes its stock is undervalued.
Analyst Ratings Changes
A number of equities analysts recently weighed in on the stock. Barclays boosted their price objective on shares of MetLife from $94.00 to $97.00 and gave the stock an “overweight” rating in a report on Thursday, August 6th. Keefe, Bruyette & Woods lifted their target price on MetLife from $105.00 to $108.00 and gave the stock an “outperform” rating in a report on Tuesday, August 11th. Piper Sandler boosted their price target on MetLife from $86.00 to $90.00 and gave the stock a “neutral” rating in a research note on Wednesday, June 24th. TD Cowen upped their price target on MetLife from $87.00 to $105.00 and gave the company a “buy” rating in a report on Wednesday, July 22nd. Finally, JPMorgan Chase & Co. lifted their price objective on MetLife from $106.00 to $108.00 and gave the stock an “overweight” rating in a report on Tuesday, August 11th. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $102.21.
Check Out Our Latest Report on MET
MetLife Company Profile
MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.
In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.
See Also
- Five stocks we like better than MetLife
- Strike a Balance Between Growth and Stability With These 3 Names Ready to Rally
- Rubrik’s AI Security Bet Could Power the Next Leg Higher
- Apple’s Foldable iPhone Could Be a Catalyst, But Not a Cure-All
- Snowflake Is Up Nearly 50% in 2026—What Are Short Sellers Betting Against?
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.
